What Are the Medications for Lung Cancer?
May 16, 2022
Source: Cainiu Health
Dr. Peng Xiaodong
Introduction
Medications for Lung Cancer
Commonly used chemotherapeutic agents include paclitaxel, docetaxel, vinorelbine, gemcitabine, pemetrexed, etoposide, carboplatin, cisplatin, and lobaplatin. The choice of chemotherapy drugs depends on the specific histopathological subtype of lung cancer.
Targeted Therapies
If a patient harbors a targetable genetic mutation, oral targeted therapy may be selected. Commonly used targeted agents include gefitinib and erlotinib.
In clinical practice, the commonly used drugs for treating lung cancer fall into several major categories. So, what are the available medications for lung cancer?
What Medications Are Used for Lung Cancer?
Commonly used chemotherapeutic agents for lung cancer include paclitaxel, docetaxel, vinorelbine, gemcitabine, pemetrexed, etoposide, carboplatin, cisplatin, and lobaplatin. The choice of chemotherapy agent depends on the specific histopathological subtype of the tumor. Targeted therapies: If a patient harbors identifiable genetic mutations, oral targeted agents may be selected—for example, gefitinib or erlotinib.
Immunotherapy: Frequently used immunotherapeutic agents include bevacizumab and nimotuzumab. Adjunctive medications—such as certain traditional Chinese patent medicines and glycopeptide-class drugs—may help enhance immune function and improve gastrointestinal function in patients. Selection among these medications is tailored to the individual patient’s histopathological subtype and disease characteristics.
For patients with advanced-stage lung cancer, combination therapy using multiple drug classes is often required. Drug selection should be guided by disease stage, histopathological subtype, and molecular profiling—including specific gene expression patterns. Some patients have higher treatment expectations and greater financial resources, warranting a comprehensive therapeutic strategy integrating chemotherapy, targeted therapy, and immunotherapy. Additionally, syndrome-differentiation-based treatment using traditional Chinese medicine (TCM) may also contribute to lung cancer management. We hope this information proves helpful to you!
